Anti-CDG2D antibodies enable researchers to detect and measure the CDG2D antigen in biological samples. This target is a reported synonym of the B4GALT1 gene, which encodes beta-1,4-galactosyltransferase 1. This protein is known to function in cell adhesion and extracellular matrix organization, among other biological roles. The human version of CDG2D has a canonical amino acid length of 398 residues and a protein mass of 43.9 kilodaltons. It is reported to be localized in the Golgi and cell membrane of cells and widely expressed in many tissue types. CDG2D is a member of the Glycosyltransferase 7 protein family. Indicated applications for CDG2D antibodies listed below include ELISA, Flow Cytometry, Western Blot, Immunocytochemistry, and Immunohistochemistry.